Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Leukemia, Myeloid, Acute 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Myelodysplastic Syndromes 17Lymphoma, Non-Hodgkin 12Hodgkin Disease 12Multiple Myeloma 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Leukemia, Lymphocytic, Chronic, B-Cell 9Myeloproliferative Disorders 8Recurrence 7Melanoma 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Biphenotypic, Acute 7Lymphoma 6Leukemia 6Anemia, Refractory, with Excess of Blasts 6Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Waldenstrom Macroglobulinemia 4Neuroblastoma 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Juvenile 4Hematologic Neoplasms 4Colorectal Neoplasms 4Burkitt Lymphoma 4Uveal Melanoma 3Stomach Neoplasms 3Primary Myelofibrosis 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

relacorilant 1olaparib 1lutetium Lu 177 dotatate 1fludarabine phosphate 1fludarabine 1Mesna 1Floxuridine 1Dexamethasone 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adrenal Cortex Neoplasms × fludarabine phosphate × 90 days × Clear all
NCT04897321 2026-05-19

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

St. Jude Children's Research Hospital

Phase 1 Recruiting
48 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Adrenal Cortex Neoplasms, Carcinoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Sarcoma, Clear Cell, Neurofibrosarcoma, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡